Gastroenterology Flashcards

1
Q

Describe Hepatitis A

A

RNA virus, spread via faecal-oral or shellfish, endemic in Africa and south america, management in supportive as infection usually self-limiting and chronicity does not occur. immunisation available. May rarely progress to fulminant hepatitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe Hepatitis B, tests, and management, and complications.

A

DNA virus, spread through blood products, IVDU, Sexual, endemic in far east, africa and Mediterranean. passive immunisation available. Chronic infection in 5% of immuno competent more common in compromised or children.

Tests: PCR Viral Load, LFTs, HIV + Hep D (increased risk of HCC progression) Antibodies screen (HBsAg following exposure, persistant denotes carrier status, HBeAg following acute illness. Antibodies to HBcAg imply past infection, antibodies to HBsAg alone) imply vaccination

Management:

  • Some I ndications for treatment include, HBV viral greater than 2000IU/mL, evidence of active liver disease, pre-existing liver disease
  • Nice guidelines recommend an initial trial with Peginterferon Alpha-2a for 48 months for chronic hepatitis. Tenofovir is recommend as an option in patients who fail to respond to interferon alone.

Complications: cirrhosis in 20%, HCC in 5-10%, fulminant hepatic failure, cholangiocarcinoma, cyroglobulinaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe Hepatitis C, its management, and complications.

A

RNA favivirus, spread through blood products, IVDU, Sexual, acupuncture, Chronic infection in 70-90%. No immunisation

Management:
Direct acting agents with specific regimes influences by the genotype (1, 2+3, 4+5+6) Simepravir (Genotype 1+4) + Sofosbuvir (All genotypes) Velpatascvir (All genotypes)

Complications: Cirrhosis, HCC, glomerulonephritis, cyroglobulinaemia, thyroiditis, autoimmune hepatitis, polyarteritis nodosa, polymyositis, porphyria cutanea tarda, non-Hodgkin’s lymphoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe Hepatitis D, and the types of infection.

A

Hepatitis D is a single stranded RNA virus transmitted parenterally. It is an incomplete RNA virus that required Hepatitis B Surface antigen to compete its replication and tramission cycle.

Hepatitis D Terminology:

  • Co-infection: Hepatitis B and Hepatitis D infection at the same time.
  • Superinfection: a hepatitis B surface antigen postive patient subsequently develops a hepatitis D infection.

Superinfection is associated with a high risk of fulminant hepatitis, chronic hepatitis status and cirrhosis.

Diagnosis is made via reverse polymerase chain reaction of hepatitis D RNA. Interferon is currently used as treatment but with a poor evidence base.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe Hepatitis E, its symptoms, investigations, and management.

A

RNA virus similar to Hepatitis A, common in indochina (thailand, Indonesia etc) mortality high in prengnancy, vaccine available in china also associated with pork consumption. Infection causes acute Hepatitis, more rarely can cause Chronic Hepatitis Particularly in immunosuppressed males age 60-70. Spread via Faecal-oral route. RNA +Ve after 3 months signifies Chronic Hepatitis E infection.

Symptoms: Jaundice, Lethargy.

Investigations: Hepatitis E Antibodies +/- RNA.

Management:

  • Mostly Conservative
  • Ribavirin may be used for chronic, or severe acute hepatitis E or Acute on Chronic Liver Failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Causes of hepatitis

A

Viral, alcohol, drugs/toxins, CMV/EBV, leptospirosis, malaria, Q fever, syphillis, yellow fever, obesity, autoimmune hepatitis, wilson’s.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe Mesenteric Ischaemia, its symptoms, and risk factors

A

Primarily caused by arterial embolism

Symptoms: presents with abdominal pain, diarrohoea, fever, rectal bleeding, metabolic acidosis, increased WBC

Risk factors: Atrial fibrillation, Increasing age, endocarditis, DVT, Cardiovascular disease, smoking, hypertension, diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the inherited causes of unconjugated hyperbilirubinaemia?

A

Gilbert’s syndrome and Crigler-Najjar syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the inherited causes of conjugated hyperbilirubinaemia?

A

Rotor’s syndrome and Dubin-Johnson syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe pancreatic cancer, it’s risk factors, signs and symptoms, tests, and management

A

Typically presents in males >60yrs old. Mostly ducal adenocarcinoma which metastasise early and present late. 60% arise in the head of the pancreas, 25% in the body and 15% in the tail. Rarely they may arise in the ampulla of vater or pancreatic islet cells both of which have better prognosis. ~95% have mutations in the KRAS2 gene

Risk factors: smoking, alcohol, DM, chronic pancreatitis, increased waist circumference and high fat/red meat diet

Signs and symptoms: tumours in the head of the pancreas present with painless obstructive jaundice. 75% of body and tail tumours present with epigastric pain that radiates to the back (relieved by sitting forward). Either may also present with weight loss, diabetes or acute pancreatitis.

Tests: ultrasound or CT imaging

Management: prognosis is poor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe Hepatocellular carcinoma its signs and symptoms, causes, test and treatment.

A

Accounts for ~90% of primary liver tumours though 90% of all liver tumours are metastatic. It is common in China and Africa (40% of cancers) and 3 times more common in men

Signs and symptoms: fatigue, decreased appetite, weight loss, RUQ pain, jaundice, ascites

Causes: HBV is leading cause, HCV, autoimmune hepatitis, cirrhosis (alcohol, haemochromatosis, PBC), NAFLD

Tests: CT, MRI and biopsy, AFP,

Treatment:
Should be managed according to the Barcelona Classification for Liver Cancer Treatment System.

Patients with Child-Pugh A cirrhosis without signs of portal hypertension who have single lesions <2cm in size should be treated with surgical resection.

For those patients with Child-Pugh A and B cirrhosis and 2-3 tumours <= 3 cm or 1 tumour <=5 cm without vascular invasion or extrahepatic spread should be considered for liver transplantation. As a bridge to liver transplantation these patients can be treated with TACE or RFA.

For those patients who have Child-Pugh A or B cirrhosis , good performance status, and evidence of vascular, lymphatic or extrahepatic spread the multiple tyrosine kinase inhibitor, Sorafenib, has been shown to prolong survival.

Those with Child-Pugh C cirrhosis have end-stage liver disease and are poor candidates for therapy as they lack any hepatic functional reserve to tolerate either resection, TACE or RFA. These patients are best treated symptomatically. Early involvement of community and/ or hospital palliative care teams should be considered. Best supportive care is therefore the correct option here.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe Hereditary haemochromatosis, it’s signs and symptoms, tests, management, and complications

A

An inherited disorder of increases intestinal iron absorption leading to deposition of excess iron in joints, liver, heart, pancreas, pituitary, adrenals and skin. Disease appears earlier and more severely in men menstrual blood loss is protective

Signs and symptoms: early may be a symptomatic or , lethargy, arthralgia (2nd+3rd MCP joints + knee psuedogout), decreased erections. Later on slate-grey skin pigmentation, chronic liver disease signs, cirrhosis, dilated cardiomyopathy, bronze diabetes, hypogonadism

Tests: Raised transferrin saturation ( over 45%) bloods also show deranged LFTs and raised serum ferritin plus elevated glucose. Echo and liver biopsy.

Management: venesection, monitor LFT and DM may progress to cirrhosis and then HCC

Complications may be split according to reversibility:

  • Irreversible: Cirrhosis, Diabetes Mellitus, Hypogonadotrophic Hypogonadism, Arthropathy
  • Reversible: Cardiomyopathy, Skin pigmentation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe Primary Biliary Cirrhosis (PBC), its presentation, tests and treatment

A

Interlobular bile ducts are damaged by chronic autoimmune granulomatous inflammation causing cholestasis which may lead to fibrosis, cirrhosis and portal hypertension. Associated with anti-mitochondrial antibodies. The M rule, Middle aged females, anti-Mitochondrial antibodies, IgM.

Presentation: typically middle-aged 50yrs, females, often asymptomatic and diagnosed after finding increased ALP on routine LFT. Lethargy, sleepiness, and pruritus may precede jaundice by years. Clubbing. Sicca syndrome occurs in 70% (also known as sjogrens)

Tests: Increased ALP, y-GT, mildly raised AST,ALT. Late disease shows hyperbilirubinaemia, hypoalbuminaemia, AMA+ve. US to exclude post-hepatic cholestasis.

Treatment:

  • Colestyramine for pruritus
  • codeine phosphate for diarrhoea
  • Vitamin ADK.
  • Ursodeoxycholic acid first line, Obeticholic acid second line
  • When jaundice develops transplantation is usually required.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe Primary Sclerosing Cholangitis (PSC), it symptom and signs, tests and treament

A

PSC entails progressive cholestasis with bile duct inflammation and strictures. Associated with HLA-A1,B8,DR3 Males, AIH and IBD especially UC. Associated with more bile duct, gallbladder, liver and colon cancer and so yearly colonoscopy and ultrasound required.

Symptoms: Pruritus +/- fatigue if advanced ascending cholangitis, cirrhosis and end-stage hepatic failure.

Tests: Raised ALP, then bilirubin, hypergammaglobulinaemia, AMA-ve but ANA, SMA and ANCA may be +ve. ERCP distinguishes large duct fro small duct disease. Liver biopsy shows a fibrous, obliterative cholangitis.

Treatment: liver transplant is the mainstay for end-stage disease, recurrence occurs in up to 30%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe Non-alcoholic fatty liver disease (NAFLD) and its risk factors.

A

Fatty liver entails steatosis +/- inflammation (steatohepatitis). Consider if a patient presents with deranged LFT (typically raised ALT) or a fatty liver on ultrasound and drink less than 18u/wk. It may progress to hepatic fibrosis +/- HCC. Typically occurs in middle-aged obese females.

Risk factors include DM, dyslipidaemia, parenteral feeding, jejuno-ileal bypass, wilson’s disease, drugs (amiodarone, methotrexate, tetracycline).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe Alcoholic Liver Disease, its symptoms, investigations, and management,

A

Primary cause of liver disease, progresses to cirrhosis in 80%. Also risks of variceal bleeding and HCC.

Symptoms: Malaise, tachycardia, anorexia, D+V, tender hepatomegaly +/- jaundice. Upper GI bleeds, ascites.

Investigations: Bloods show raised WCC, low platelets, increased INR, AST, MCV and urea. AST:ALT ratio is typically >2. If ALT is higher think of an ALTernative diagnosis. AST rarely exceeds 500 and ALT rarely exceeds 300

Management:
-Prednisolone 40mg PO OD 4wks after an infection screen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe Cirrhosis, its causes, signs, investigtions, and complications.

A

Cirrhosis implies irreversible liver damage characterised histologically by loss of normal hepatic architecture with bridging fibrosis and nodular regeneration.

Causes: Most often chronic alcohol abuse, HBV, HCV infection. Others include haemochromatosis, a1AT deficiency, wilson’s disease, NAFLD, PBC, PSC, AIH, drugs (amiodarone, methyldopa, methotrexate)

Signs of chronic liver disease: leuconychia, clubbling, palmar erythema, hyperdynamic circulation, Dupuytren’s contracturem spider naevi, xanthelasma, gynaecomastia, atrophic testes, loss of body hair, partoid enlargement, hepatomegaly.

Signs for decompensated liver disease: ascites, jaundice, encephalopathy.

Tests: Raised bilirubin, AST, ALT, ALP, yGT. decreased Albumin. Decreased platelets and WCC indicate hypersplenism. liver biopsy confirms diagnosis. ascitic tap

Complications:

  • hepatic failure = coagulopathy, encephalopathy, hypoalbuminaemia, sepsis, Spontaneous Bacterial Peritonitis (more than 250cells/mm3 of ascitic fluid), hypoglycaemia
  • Portal hypertension = ascites, splenomegaly, oesophageal varices, low platelets.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe Autoimmune Hepatitis its typical presentation, types, tests and management.

A

An inflammatory liver disease characterised by suppressor T-cell defects with autoantibodies against hepatocyte surface antigens. AIH predominantly affects young or middle-aged women.

Presentation: Up to 40% present with acute hepatitis (fever, jaundice, RUQ pain) and signs of autoimmune disease e.g. fever, malaise, urticarial rash, polyarthritis, pleurisy, pulmonary infiltration or glomerulonephritis, amenorrhoea,

Types:

  • AIH 1: Positive ANA and SMA, Anti-actin, elevated in IgG
  • AIH 2: Positive LKM-1 (Tyically female children/teenagers, rare in adults)
  • AIH 3: Positive Soluble liver antigen antibodies.

Tests: serum bilirubin, AST, ALT and ALP are usually raised, hypergammaglobulinaemia, +ve autoantibodies (e.g. Antismooth muscle antibodies, ANA).

Management: Immunosuppression with prednisolone 30mg/d PO for a month decreasing by 5mg a month to maintenance dose of 5-10mg/d. Azathioprine may be used a steroid-sparing agent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is a Hernia?

A

A hernia is the protrusion of a viscus or part of a viscus through the walls of its containing cavity into an abnormal position

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe Ulcerative Colitis, its symptoms and signs, investigations, and management.

A

Relapsing, Remitting inflammatory disorder of the colonic mucosa, proctitis in 50%, left-sided colitis in 30%, or pancolitis in 20%. It does not spread proximal to the oleo areal valve (except for backwash ileitis). There is hyperaemic/haemorrhagic granular colonic mucosa +/- pseudopolyps formed by inflammation. 3x as common in non-smokers, symptoms may relapse on smoking cessation.

Symptoms + Signs:
Episodic or chronic diarrhoea +/- blood and mucus, crampy abdominal discomfort, bowel frequency related to severity. Proctitis may present with urgency/tenesmus. Systemic symptoms include fever, malaise, weight loss. There may be clubbing, aphthous oral ulcers, erythema nodosum, pyoderma gangrenosum, large joint arthritis, conjunctivitis, Ankylosing spondylitis, Primarmy sclerosing cholangitis.

Investigations:
Bloods: 
-FBC (may show anaemia)
-ESR (greater than 30mm/hr in severe UC)
-CRP (raised inflammatory marker)
-LFT (evidence of extra-intestinal involvement)
-pANCA
Stool MC+S to exclude infectious cause. 
Imaging:
-AXR (mucosal thickening, colonic dilatation
-CXR (exclude perforation)
-Colonoscopy shows disease extend and allows biopsy (shows inflammatory infiltrate, depleted goblet cells, glandular distortion, mucosal ulcers, crypt abscesses)

Management:
-assess severity with truelove+witts criteria.

Inducing Remission:

  • Mild UC, 5-ASA e.g. Sulfasalazine or Mesalazine + Steroids e.g. Prednisolone 20mg/d PO or enema. If improving in 2 weeks ween of steroid otherwise treat as moderate UC.
  • Moderate UC, try Prednisolone 40mg/d PO 1wk, then 30mg/d 1wk, then 20mg/d 4wks + 5-ASA + TDS Steriod enemas. If improving, ween of steroids otherwise treat as severe UC.
  • Severe UC, admit, NBM + IV hydration. Hydrocortisone 100mg/6h IV. Rectal Steroids. Monitor vitals if improving in in 5d Predinisolone 40mg/d PO and 5-ASA to maintain remission. If continued trouble action such as surgery or rescue therapy with ciclosporin or infliximab may be needed.

Maintaining remission: All 5-ASAs decrease relapse rate from 80% to 20%. Sulfasalasine is first line SEs include headache, nausea, hyperthermia, rash, haemolysis (monitor FBC and U+E at start, then at 3 months and then annually), hepatitis, pancreatitis, paradoxical worsening of colitis, reversible oligospermia. Mesalazine has reduced side-effect profile but is more expensive reserve for those intolerant or young men.
Surgery: this is needed at some stage in 20% e.g. Proctocolectomy + terminal ileostomy. Indications are perforation, massive haemorrhage, toxic dilatation, failed medical therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe Dyspepsia/Peptic Ulcer Disease, its symptoms, red flags, and management.

A

Dyspepsia (indigestion), may be functional (non-ulcer) or be associated with ulcers either duodenal or gastric. Duodenal ulcers are x4 more common than gastric, gastric mainly occur in the elderly.

Symptoms: Epigastric pain often related to hunger (pain before meals relieved by eating = duodenal, pain after food relieved by antacids = gastric) +/- bloating, fullness after meals, heartburn (retrosternal burning pain caused by reflux), tender epigastrium.

Red Flags:
ALARM Symptoms = Anaemia, Loss of weight, Anorexia, Recent onset/progressive symptoms, Melena/haematemesis, Swallowing difficulty.

Management:

  • refer for upper GI endoscopy under 2WW if over 55yrs and ALARM Symptoms.
  • If not stop drugs causing dyspepsia such as NSAIDs, lifestyle changes such as weight loss, smoking cessation, avoiding acidic foods, trial over-counter antacids, review in 4wks.
  • No improvement, test for H.pylori if +ve triple eradication therapy, (Omeprazole, clarithromycin, amoxicillin ) must be PPI free for 2 weeks
  • Trial with PPI e.g. Omeprazole, or lansoprazole. Or ranitidine H2 Antagonists.
  • If still no improvement consider upper GI endoscopy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are some causes of Constipation?

A

Causes:

  • General e.g. Poor diet, lack of exercise, poor fluid intake, IBS, old age, hospital environment
  • Anorectal disease (especially if painful) e.g. Anal or colorectal cancer, fissures, strictures, rectal prolapse, proctaglia fugax, mucosal ulceration, pelvic muscle dysfunction
  • Intestinal obstruction e.g. Colorectal carcinoma, strictures (crohn’s), pelvic mass, diverticulosis, pseudo-obstruction.
  • Metabolic/endocrine e.g. Hypercalcaemia, Hypokalaemia, porphyria, lead poisoning.
  • Drugs e.g. Opiates, anticholinergics, iron, diuretics, calcium channel blockers.
  • Neuromuscular e.g. Spinal or pelvic nerve injury, aganglionosis, diabetic neuropathy
  • Other e.g. Psychological, anorexia nervosa, depression, child abuse.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Describe Crohn’s Disease, it’s presentation, investigations, and management.

A

A chronic inflammatory GI disease characterised by transmural granulomatous inflammation affecting any part of the gut from mouth to anus (especially terminal ileum). Unlike UC these is unaffected bowel between areas of active disease (skip lesions). Usually presents between 20-40yrs. Smoking increased risk and NSAIDs may exacerbate disease.

Presentation: Diarrhoea/urgency, abdominal pain, weight loss, fever, malaise, anorexia. Other signs include aphthous ulcerations, abdominal tenderness, perianal abscess/fistulae/skin tags. Clubbing, joint and eye problems also occur.

Investigations:

  • Bloods FBC, ESR, CRP, LFT, INR, Ferritin, B12.
  • Anti-Saccharomyces Cerevisae Antibodies
  • Colonoscsopy + rectal biopsy.

Management:

  • Sole source liquid formula diet has shown to be as effective as steroids.
  • Prednisolone for mild attacks/remission
  • azothioprine as steroid sparing agent.
  • sever attacks require IV hydrocortisone, and metronidazole.
  • If not under control can move towards methotrexate and TNF-a inhibitors.
  • Metronidazole is first line for perianal disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe Coeliac Disease, it’s presentation, investigation, and management.

A

T-cell mediated autoimmune disease of the small bowel in which prolamin (gluten) intolerance cause villous atrophy and malabsoprtion. It is associated with HLA DQ2 in 95% and DQ8 in the rest. Also associated with other autoimmune disease and dermatitis herpetiformis.

Presentation: stinking stools/ steattorrhoea, diarrohoea, abdominal pain, bloating, aphthous ulcers, angular stomatitis, weight loss, lethargy, failure to thrive.

Investigations:

  • Bloods FBC (anaemia), increased RCDW (mixed megaloblastic and microcytic picture) low Ferritin (iron-deficiency), Low B12. Antibodies e.g. Alpha-gliadin, transglutaminase and anti-endomysial antibodies. They are IgA so check IgA levels in case of deficiency.
  • Endoscopy, jejuno or duodenal biopsy shows subtotal villous atrophy, intra-epithelial WBCs, crypt hyperplasia. Beware negatives results if already on gluten-free diet.
Management:
-life-long gluten free diet.
-advice on coeliac UK charity
-increase risk of GI T-cell lymphoma if poorly controlled monitor by testing antibodies.
-
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Describe Appendicitis, its symptoms, tests, complications, and management.

A

Most common surgical emergency. Can occur at any age but highest incidence is in 10-20yrs. It is rare before the age of 2.

Symptoms: classically peri umbilical pain that moves the right iliac fossa. Anorexia is an important feature, committing is rarely prominent and normally preceded by pain. Constipation is usual though diarrohoea may occur. There may be guarding, rebound + percussion tenderness. Tachycardia, Fever (37.5-38.5), furred younger, lying still, coughing hurts, shallow breaths. Rovsing’s sign (pain worse in RIF when LIF pressed), Psoas sign (pain on extending hip if retrocaecal appendix), Cope sign (pain on flexion and internal rotation of right hip if appendix in close relation to obturator internus)

Tests: Bloods may show neutrophil leucocytosis, elevated CRP. USS may help, CT has high diagnostic activity if diagnosis unclear.

Complications:

  • perforation, commoner in children as diagnosis is often delayed.
  • Appendix mass, appendix abscess.

Management:

  • inform on-call GI surgeon, admit
  • Prompt appendicectomy
  • Abx metronidazole 500mg/8h + Cefuroxime 1.5g/8h
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the King’s College Hospital criteria for liver transplantation?

A

Paracetamol-induced liver failure:

  • arterial pH less than 7.3 24h after ingestion or all of the following
  • Prothrombin time greater than 100s
  • creatinine over 300umol/L
  • Grade III or IV encephalopathy

Non-Paracetamol Liver Failure

  • PT over 100s OR 3 of 5 of the following:
  • Drug induced liver failure
  • less than 10yrs old or over 40
  • at least 1wk between jaundice to encephalopathy
  • PT over 50s
  • Bilirubin over 300umol/L
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Describe Acute Pancreatitis, it’s causes, symptoms, and management.

A

Causes: GET SMASHED, Gallstones, Ethanol, Trauma, Steroids, Mumps, Autoimmune, Scorpion venom, Hypertriglyceridaemia + Hypercalcemia + Hypothermia, ERCP, Drugs e.g. Azothioprine, mesalazine, Bendroflumethiazide, steroids, sodium valproate.

Symptoms: Severe constant epigastric pain or central abdominal radiating to back, sitting forward may relieve (this pain is due to irritation to the coeliac ganglion), vomiting, low-grade fever, abdominal tenderness, ileus, peri umbilical discolouration (Cullen’s sign) and flank discolouration (grey-turners signs).

Management:

  • check BMG and SpO2
  • serum amylase/lipase likely to be high over 5x upper limit
  • FBC may show high WCC
  • U+E, Ca2+, Glucose (Hypocalcaemia is relatively common)
  • coagulation screen
  • CXR, ECG, ABG, lactate if unwell
  • IV fluids, analgesia + anti-emetic
  • Insert NG tube
  • Urinary catheter monitor UO
  • Ranson/Glasgow scoring criteria
  • refer to medical team/HDU
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Describe Ascending Cholangitis, its symptoms and management.

A

A bacterial infection of the biliary tree. Most common predisposing factor is gallstones.

Symptoms: Charcot triad of RUQ pain, fever and jaundice occurs in about 20-50% of patients. Fever is most common followed by RUQ and then jaundice. May also be hypotensive and/or confused.

Management:

  • IV antibiotics e.g. Cefuroxime and Metronidazole
  • ERCP after 24-48hrs to relieve any obstruction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Describe Acute Cholecystitis, its symptoms, and management.

A

Follows stone or sludge impaction in the neck of the gallbladder.

Symptoms: Colicky pain but more severe and persistent, it may radiate to the back or right shoulder. Patient may be pyrexial and Murphy’s sign positive I.e. Arrest of inspiration on palpation of RUQ.

Management:

  • NBM, pain relief, Cefuroxime.
  • laparoscopic cholecystectomy is treatment of choice for all patients fit for GA.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Describe Irritable Bowel Syndrome, its symptoms, red flags, and management.

A

A group of abdominal symptoms for which no organic cause can be found. Most are likely due to disorders of interstitial motility or enhanced visceral perception. Faecal calprotectin can exclude IBD.

Symptoms: Abdominal pain relieved by defecation or associated with altered stool form and at least 2 of urgency, incomplete evacuation, abdominal bloating, worsening symptoms after food. Symptoms are chronic and exacerbated by stress, menstruation.

Red Flags: age over 40yrs, history less than 6 months, anorexia, weight loss, waking at night with pain/diarrhoea, mouth ulcers, abnormal CRP, ESR, Hb, coeliac serology. Investigate PR bleeding urgently.

Management:

  • Ensure healthy diet
  • Fibre, lactose, fructose, wheat, starch, caffeine, sorbitol, alcohol, fizzy drinks can worsen symptoms try modifying diet to balance symptoms.
  • anti-spasmodic S e.g. Mebeverine may help
  • Psychological wellbeing +/- CBT amitryptilline can help.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Describe Hereditary Haemorrhagic Telangiectasia and its diagnostic criteria

A

Aka Osler-Weber-Rendu disease, a rare autosomal dominant disorder characterised by multiple telangiectasia over the skin and mucous membranes. 20% of cases occur spontaneously without prior FHx

Symptoms: 4 main diagnostic criteria 2 = possible diagnosis, 3 or more is definite diagnosis:

  • Epistaxis - spontaneous, recurrent nosebleeds
  • Telangiectases: multiple at characteristic sites (Lips, oral cavity, fingers, nose)
  • visceral lesions - e.g. GI bleeding, Pulomary AV malformations, Hepatic AVM, Cerebral AVM, spinal AVM
  • FHx - (first degree relative).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Describe Peutz-Jeghers syndrome, its genetics, features, and management.

A

Autosomal Dominant disorder characterised by numerous hamartomatous polyps in the GI Tract. It is also associated with pigmented freckles on the lips, face, palms and soles. There is a 15-fold increased risk of GI cancer and around 50% will have died from a GI cancer by the age of 60.

Genetics: Autosomal dominant, mutations of tumour suppressor gene STK11 or LKB1

Features:

  • Hamartomatous polyps in GI tract.
  • Pigmented mucocutaneous dark freckles on lips, oral mucosa, palms and soles
  • intestinal obstructio or intussception
  • GI bleeds.

Management:

  • Conservatice unless complications develop
  • Perform colonoscopy (from age 18) and OGD (from age 25) every 3yrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Describe Bowel Obstructions, the types, symptoms, and management.

A

Types:

  • Small Bowel Obstruction: Vomiting present earlier, distension is less, and pain is higher in the abdomen. AXR shows central gas shadows with valvulae conniventes that completely cross the lumen and no gas in the large bowel.
  • Large Bowel Obstruction: Pain is more constant, more distension. AXR shows dilated large bowel with Haustra peripherally arranged.

Symptoms: Vomiting, Colicky pain, constipation, distension,

Management:

  • Drip and Suck, NGT and IV fluids
  • Consider CT to look for cause of obstruction
  • if strangulated emergency surgery is needed.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Describe Zollinger-Ellison Syndrome, its symptoms, investigations, and management.

A

Gastrin-secreting tumour, which cause multiple refractory and recurrent peptic ulcers. Can present as MEN1 Autosomal dominant disorder

Symptoms: Epigastric pain, diarrhoea, weight loss, GI bleeding. Treatment resistant dyspepsia.

Investigations:
-FBC may show IDA, Ferritin may be low, Parathyroid hyperplasia is a common feature of MEN1, Calcium may be elevated. H.Pylori testing, endoscopy if severe or red-flags, 3 x fasting Gastrin levels, prolactin levels, CT for staging

Management:

  • ABCDE approach if GI bleeding.
  • Oral PPIs
  • Surgical resection of primary tumour.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Describe Chronic Pancreatitis, it’s causes, symptoms, investigations, and management.

A

Symptoms: Epigastric pain ‘bores’ through to back, relieved by sitting forward or hot water bottles on epigastrium, also bloating, steattorrhoea, weight loss, brittle diabetes.

Causes: Alcohol mostly, rarely familial, CF, haemochromatosis, pancreatic duct obstruction, Hyperparathyroidism, congenital.

Investigations: US +/- CT looking for pancreatic calcification.

Management:

  • analgesia
  • insulin for diabetic needs
  • alcohol cessation
  • lipase + fat so;unless vitamins.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Describe Diverticular Disease, it’s symptoms, complications and management.

A

Outpouching of gut wall, which may become inflamed. They can be congenital or more commonly acquired through age.

Symptoms: There may be later altered bowel habit plus left-sided colic relieved by defecation. Nausea and flatulence. Diarrohoea may occur if inflamed.

Complications:

  • perforation
  • haemorrhage usual cause of big rectal bleeds
  • fistulae
  • abscess

Management:

  • due to symptoms referral should be made for colonoscopy to exclude bowel cancer
  • high fibre diet may help
  • mebeverine may help
  • Abx if fever and diarrhoea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

With regards to Ascitic Fluid how are transudates and exudates differentiated and what are some causes of each?

A

They are classified according to serum-ascites albumin gradient (SAAG) = Serum Albumin - Ascitic fluid albumin

More than 11g/L = High SAAG = transudate
Less than 11g/L = Low SAAG = Exudate

Transudate causes: Cirrhosis, hepatic failure, hepatic venous occlusion, constrictive pericarditis, kwashiorkor, Cardiac failure, alcoholic hepatitis, liver metastasis

Exudate causes: Malignacy, infection, pancreatitis, nephrotic syndrome, bowel obstruction or infarction, bile leak.

38
Q

What are the causes of a massive transaminitis?

A

AST/ALT over 1000

Causes:
Viral Hepatitis
Drug-induced liver failure
Ischaemic Hepatitis

39
Q

What are the grades of Hepatic Encephalopathy?

A

Grade 1: Altered mood/behaviour, sleep disturbance, dyspraxia, poor arithmetic, no liver flap

Grade 2: Increasing drowsiness, confusion, slurred speech +/- liver flap, inappropriate behaviour/personality change.

Grade 3: incoherent, restless, liver flap, stupor

Grade 4: Coma

40
Q

Describe Portal Hypertension, the pathophysiology, its causes, features and management.

A

Clinically significant portal hypertension is defined as an hepatic venous pressure gradient of 10mmHg or more.

Pathophysiology: Increased vascular resistance from various mechanical causes and also as an active process in which liver damage activates stellate cells and myofibroblasts, contributing to abnormal blood flow patterns. Increased blood flow from splanchnic arteriolar vasodilatation, causes by an excessive release of endogenous vasodilator. This pressure leads to venous collaterals to open up connecting the portal and venous systems, these occur in various sites e.g. Gastro-oesophageal junctions (varices) anterior abdominal wall (caput medusae). These collaterals can lead to encephalopathy due to various toxins bypassing the liver.

Causes:

  • Pre hepatic e.g. Congenital atresia, portal vein thrombosis (idiopathic, umbilical and portal sepsis, malignancy, hypercoagulable states, pancreatitis) splenic vein thrombosis, extrinsic compression from tumours.
  • Hepatic e.g. Cirrhosis, chronic hepatitis, schistosomiasis, myeloproliferative diseases, idiopathic portal hypertension, granulomata e.g. Sarcoidosis, fibropolycystic disease.
  • Posthepatic: budd-chiari syndrome (hepatic vein obstruction), Right heart failure, constrictive pericarditis

Features: splenomegaly, ascites, caput medusae, signs of liver failure.

Management:

  • Salt restriction and diuretics
  • non-selective b-blockers e.g. Propranolol, carvedilol
  • terlipressin
  • trans jugular intarhepatic portosystemic shunt (TIPS).
  • Rifaximin a poorly absorbed form of Rifampacin used to treat/prevent hepatic encephalopathy by eradicating ammoniagenic bacteria in the GI tract.
41
Q

Describe Hepato-renal syndrome, the types and management

A

Cirrhosis + ascities + renal failure is the triad if other causes of renal impairment have been excluded. Abnormal haemodynamics causes splanchnic and systemic vasodilatation, but renal vasoconstriction.

Types:

  • HRS 1 is a rapidly progressive deterioration (doubling of Serum creating to more than 221 in less than two weeks) in circulatory and renal function often triggered by other deteriorating pathologies e.g. Varicella bleed, SBP. Terlipressin replenishes hypovolaemia. Haemodialysis may be needed.
  • HRS 2 is a more steady deterioration. Transjugular intraheptic protosystemic shunting is the best option for most.

Management:

  • depending on type as above.
  • terlipressin + Human albumin solution can help
  • if failure to respond, transplantation needed including renal transplant if failure ongoing over 3months.
  • transjugular intrahepatic portosystemic shunt May also have a role.
42
Q

Describe Wernicke’s Encephalopathy, its symptoms and management.

A

A syndrome due to thiamine (Vitamin B1) deficiency. Often due to chronic alcohol consumption. Left untreated it may progress into Korsakoff’s syndrome a irreversible neuropsychiatric condition characterised by marked impairment of short term memory.

Symptoms: The classical triad is ataxia, opthalmoplegia and confusion.

Management:

  • high dose thiamine usually administered IV in the form of Pabrinex ( a combination preparation of B and C vitamins) it is prescribed as a 2 pairs of ampules each pair consisting of 2 5ml ampules and infused over 30minutes.
  • be sure to correct thiamine first as other fluids and medications such as Dextrose can use up remaining thiamine stores and potentiate Wernicke’s Encephalopathy
43
Q

What is the ligament of Treitz and its clinical significance?

A

A suspensory muscle of the duodenum, it is a thin muscle connecting the junction between the duodenum, jejunum and duodenojejunal flexure to connective tissue surrounding the superior mesenteric atery and coeliac artery.

The ligament is an important anatomical landmark of the duodenjejunal flexure, separating the upper and lower gastrointestinal tracts.

44
Q

What is the name for PR bleeding?

A

Haematochezia

45
Q

Describe the Child-Pugh score.

A

Score for prognosis in chronic liver disease and cirrhosis. Scoring 5 parameters 1,2,3 points as follows:

INR: 1.7, 1.7-2.3, 2.3
Albumin: 35, 28-35, 28
Bilirubin: 34 34-50, 50
Ascites: none, mild, moderate
Encephalopathy: none, I-II, III-IV

Grade A = 5-6 points 1year survival 100%
Grade B = 7-9 points 1 year survival 80%
Grade C = 10-15 points 1 year survival 45%

46
Q

Describe Plummer-Vinson syndrome, its features, and management.

A

Increased risk of perforation of oesphagus and developing squamous cell carcinoma of the oral cavity, oesophagus and hypopharynx.

Features: Dysphagia, odynophagia, Iron-deficiency anaemia, oesphogeal webs

Management:

  • Ferrous sulphate 200mg BD
  • mechanical widening of the oesphagus during endoscopy
47
Q

Describe Oesophageal rupture, its causes, features and management.

A

Causes:

  • Iatrogenic e.g. Endoscopy/biopsy/dilatation
  • Trauma e.g. Penetrating injury/ingestion of foreign body
  • Carcinoma
  • Boerhaave syndrome, rupture due to violent vomiting
  • corrosive ingestion

Features: Odynophagia, tachypnoea, dyspnoea, fever, shock, surgical emphysema CXR pneumomediastinum, V sig

Management:

  • iatrogenic are less prone to mediastinitis and sepsis and may be managed conservatively with Ng tube PPI and ABx
  • others require ABCDE rests, antibiotics, antifungals, and surgery including debridement of mediastinum and placement of t tube for drainage and formation of a controlled oesophageal cutaneous fistula.
48
Q

What are the causes of painful hepatomegaly?

A

Hepatic Abscess
Liver mets
CCF
Hepatitis

49
Q

Describe Porphyria Cutanea Tarda, its features, investigations and management.

A

Most common hepatic porphyria. Due to an inherited defect in uroporhyrinogen dexcarboxylase or caused by hepatocyte damage e.g. Alcohol, hepatitis C, Oestrogens

Features: Classically photosensitive rash with blistering and skin fragility on the face and dorsal aspect of hands, hypertrichosis (excessive hair growth), hyperpigmentation

Investigations:
-urine elevated uroporphyrinogen and pink fluorescence of urine under Woods lamp (UV Light)

Management:

  • Chloroquine
  • Venesection
50
Q

Describe Curling’s Ulcer

A

An acute gastric erosion resulting as a complication from severe burns when reduced plasma volume leads to ischaemia and cell necrosis (sloughing of the gastric mucosa).

51
Q

Describe Acute Intermittent Porphyria, its features, and investigations.

A

A metabolic disorder affect production of Haem. It is caused by porphobilinogen deaminase deficiency, leading to a build up of neurotoxic metabolites porphobilinogen and amino-laevulinic acid in the cytoplasm.

Features: episodic attacks of peripheral (usually upper limb) and autonomic neuropathy (abdo pain, hypertension) , psychiatric symptoms (unlike other porphyria no photosensitive rash), SIADH

Drug precipitators: Barbituates, halothane, benzodiazepines, alcohol, OCP, Sulphonamides.

Investigations: Hyponatraemia, Urinary porphyria screen, including porphobilinogen

52
Q

Describe Achalasia, its features, investigations, types, and management.

A

The lower oesophageal sphincter fails to relax due to degeneration of the myenteric plexus.

Symptoms: dysphagia (for fluids and solids), regurgitation, substernal cramps, and weight loss

Investigations:
-CXR shows fluid level in dilated oesophagus, Barium swallow shows dilated tapering oesophagus (bird’s beak). Oesophageal Manometry

Types:

  • Type 1 Classic, with minimal contractility in the oesophageal body
  • Type 2 with intermittent periods of panoesophageal pressurisation
  • Type 3 Spastic with premature or spastic distal oesophageal contractions.

Management:

  • Non-surgical, calcium channel blockers and nitrates may help relax sphincter and botulin injections
  • Endoscopic balloon dilatation or Heller’s myotomy. Peroral Endoscopy Myotomy (Myotomy is preferred in patients less than 40 with Type III)
  • PPIs, increased risk of squamous oesophageal cancer.
53
Q

What is Melanosis coli?

A

A disorder of pigmentation of the bowel wall. Histology demonstrates pigment-laden macrophages.

It is associated with laxative abuse, especially anthraquinone compounds such as senna.

54
Q

What EEG changes are seen in hepatic encephalopathy?

A

High amplitude, low frequency delta waves

Triphasic waves

55
Q

Describe Gardner syndrome and its features

A

A variant of familial adenomatous polyposis. Autosomal dominant disease.

Features:

  • Multiple osteomas (skull bones typically)
  • Skin and soft tissue tumours
  • GI polyps / Polyposis Coli
56
Q

Describe the main Gastrointestinal hormones, their source and actions within the GI system.

A

Gastrin - Secreted by G cells in the antrum of stomach. Act to increase HCL, pepsinogen and IF secretion, increases gastric motility and stimulates parietal cell maturation.

Cholecystikinin (CCK) - Secreted by I Cells in the upper small intestine. Act to increase exocrine activity of pancreas, contraction of gallbladder, and relaxation of sphincter of Oddi, decreases gastric emptying. Induces satiety.

Secretin - Secreted by S cells in the upper small intestine, acts to increase bicarbonate secretion from pancreas, decreased gastric acid secretion.

Somatostatin - Secreted by D cells in the pancreas and stomach, acts to decreased acid and pepsin secretion, decreases gastrin secretion, and pancreatic enzyme secretion. Decreases insulin and glucagon secretion, stimulates gastric mucus production.

57
Q

What are some causes of Pneumobilia?

A

Recent biliary instrumentation:

  • ERCP
  • Percutanous cholangiography

Incompetent sphincter of Oddi:

  • Sphincterotomy (50% have pneumobilia at 1yr)
  • Follow passage of a gallstone
  • Scarring e.g. Chronic pancreatitis
  • Drugs e.g. Atropine
  • congenital

Biliary-enteric surgical anastomosis:

  • Cholecystoenterostomy
  • choledochoduodenostomy
  • Whipple’s procedure

Spontaneous biliary-enteric fistula:

  • Gallstone Ileus
  • Peptic ulcer disease
  • Traumatic
  • Neoplasm e.g. Cholangiocarcinoma, ampullary cancer

Infection:

  • Cholangits
  • Emphysematous cholecystitis
  • Liver abscess
58
Q

Describe the severity classification of ulcerative colitis.

A

Formally determined using truelove-wittz criteria

Mild: less than 4 stools/day, only small amount of blood
Moderate: 4-6 stools/day, varying amount of blood, no systemic upset
Severe: more than 6 stools/day, features of systemic upset e.g. Pyrexia, tachycardia, anaemia, raised inflammatory markers.

59
Q

Describe the management of ulcerative colitis.

A

Inducing remission:

  • Treatment depends on the severity of disease
  • rectal (topical) aminosalicylates or steroids (for distal colitis rectal mesalazine has been shown to be superior to rectal steroids and oral aminosalicylates)
  • Oral aminosalicylates
  • Oral prednisolone is usually used second-line for patients who fail to respond to aminosalicylates. NICE recommend waiting 4 weeks before deciding if initial treatment has failed.
  • severe colitis should be treated in hospital with IV steroids first line.

Maintaining remission:

  • oral aminosalicylates e.g. Mesalazine
  • Azathioprine and mercaptopurine (Methotrexate is not recommended)
  • may require surgical resection
60
Q

Describe Budd-Chiari syndrome, its causes, and features.

A

Aka Hepatic Vein Thrombosis, is usually seen in the context of underlying haemotological disease or another procoagulant condition.

Causes:

  • Polycythaemia Rubra Vera
  • Thrombophilia e.g. Activated protein C resistance, Antithrombin III deficiency, Protein C+S deficiencies
  • Pregnancy
  • COCP

Features:

  • Abdominal Pain sudden onset and severe
  • Ascites
  • Tender hepatomegaly
61
Q

Describe the classifications of stool as described by the Bristol stool chart

A

Type 1: Separate hard lumps like nuts hard to pass
Type 2: Sausage-shaped but lumpy
Type 3: Like a sausage but with cracks on its surface
Type 4: Like a sausage or snake, smooth and soft
Type 5: soft blobs with clear-cut edges (passed easily)
Type 6: Fluffy pieces with ragged edges, a mushy stool
Type 7: Watery, no solid pieces, Entirely liquid

62
Q

Describe Dublin-Johnson syndrome

A

A benign autosomal recessive disorder resulting in conjugated hyperbilirubinaemia. It is due to a defect in the canillicular multispecific organic anion transporter (cMOAT) protein. This cause defective hepatic bilirubin excretion.

63
Q

Describe Crigler-Najjar syndrome and its types.

A

Unconjugated hyperbilirubinaemia

Type 1: autosomal recessive, absolute deficiency of UDP-glucuronosyl transferase, do not survive to adulthood

Type 2: slightly more common and less severe may improve with phenobarbital.

64
Q

What is Kantor’s string sign, and what are some causes?

A

Refers to string-like appearance of a contrast-filled bowel loop caused by severe narrowing of a bowel loop e.g. Stricture.

Causes: Crohn’s, hypertrophic pyloric stenosis, gastrointestinal TB, Carcinoid tumour and colon cancer.

65
Q

What is a Fibroscan?

A

Fibroscan uses elastography, a technique similar to ultrasound that measures the stiffness of the liver. It is a non-invasive, painless alternative to liver biopsy.

66
Q

What does APC stand for?

A

Argon Plasma Concentration i.e. Laser therapy in colonoscopy etc.

67
Q

What criteria must be met in order to ensure patients presenting with paracetamol OD are safe for discharge post 21hr NAC infusion?

A

INR is 1.3 or less AND
ALT is less than two times the upper normal AND
ALT is not more than double the admission measurement.

68
Q

Describe the management of Crohn’s disease.

A

General Points:

  • Patients should be strongly advised to stop smoking
  • some studies suggest an increased risk of relapse secondary to NSAIDs and COCP

Inducing Remission:

  • Glucocorticoids
  • enteral feeding -
  • 5-ASA drugs e.g. Mesalazine are used second-line to glucocorticoids but are not as effective
  • Azathioprine or mercaptopurine may be used as an add-on medication to induce remission but not used as monotherapy, methotrexate is an alternative.
  • Infliximab is useful in refractory disease and fistulating crohn’s. Patients typically continue on azathioprine or methotrexate.
  • Metronidazole is often used for isolated peri-anal disease.

Maintaining remission:

  • as above, stopping smoking is priority
  • sole source liquid diet has been shown to be effective.
  • Azathioprine or mercaptopurine is used first-line to maintain remission
  • Methotrexate is used second-line
  • 5-ASA drugs should be considered if a patient has had previous surgery.

Surgery:

  • around 80% of patient will eventually have surgery.
  • commonest disease pattern is structuring terminal ideal disease and this often culminates in an ileocaecal resection.
  • Other procedures include segmental small bowel resections and stricturoplasty.
  • Colonic involvement in patients with crohn’s is not common and when found often segmental, despite this their is high recurrence rate so surgical approach for colonic disease is generally subtotal colectomy, panproctocolectomy, and staged sub total colectomy and proctectomy.
69
Q

Describe VIPoma and its features.

A

VIP (Vasoactive Intestinal Peptide):

  • Source: Small intestine, pancreas
  • Stimulation: neural
  • Actions: stimulates secretion by pancreas and intestines, inhibits acid and pepsinogen secretion.

VIPoma: 90% arise from pancreas

Features:
-Large voluble diarrhoea, weight loss, dehydration, hypokalaemia, hypochlorhydia.

70
Q

Which tests make up a non-invasive liver screen?

A
LFTs inc Gamma-GT, AST
Ethanol
Coagulation
Hepatitis Serology, A/B/C
Viral Screen CMV/EBV/HIV
Ferritin and TIBC
Alpha-1 Antitrypsin
Immunoglobulins and Electrophoresis
Autoantibody screen (Anti-mitochondrial, LiverKidney Microsomal antibody Anti-smooth muscle)
AFP
Serum Copper, Caeruloplasmin +/- 24hr Copper
71
Q

Describe the FIB-4 Score and its use

A

The FIB-4 scoring system uses a combination of patient age, platelet count, AST and ALT to identify patients at risk of liver fibrosis.

A score less than 1.45 has a Negative predictive value of 90% for advanced liver fibrosis. A score over 3.25 has a Positive predictive value of 65% with a specificity of 97%.

A score over 1.45 should be referred for a fibroscan.

72
Q

Describe Drug Induced Liver Disease, its types and causes.

A

Drug induced liver disease is generally divided into Hepatocellular, Cholestatic or mixed. There is however some considerable overlap with some drugs causing a range of changes to the liver.

Hepatocellular (Raised ALT):

  • Paracetamol
  • Sodium Valproate, Phenytoin
  • MAOIs
  • Halothane
  • Anti-TBs
  • Statins
  • Alcohol
  • Amiodarone
  • Methyldopa
  • Nitrofurantoin

Cholestatic (+/- Hepatitis):

  • COCP
  • Antibiotics e.g. Flucloxacillin, Co-amoxiclav, Erythromycin
  • Anabolic steroids, testosterone
  • phenothiazines e.g. Chlorpromazine, Prochlorperazine
  • Sulphonlyureas
  • Fibrates
  • Nifedipine

Liver Cirrhosis:

  • Methotrexate
  • Methydopa
  • Amiodarone
73
Q

Describe Spincter of Oddi Dysfunction, its features, types and management

A

Aka post-cholecystectomy syndrome. recognised complication of cholecystectomy. Thought to be due to remnant stones and biliary injury. Pain is often due to sphincter of Oddi dysfunction and the development of surgical adhesions.

Features: Dyspesia, vomiting, pain, flatulence, and diarrhoea. Diagnosed by manometers, although delayed drainage of contrast at ERCP (more than 45mins) is characteristic.

Types:
1 = People with typical biliary pain, abnormal LFTs and radiologically evidence of impaired biliary drainage
2 = People wit typical biliary pain with either abnormal LFTs or Radiological evidence of impaired biliary drainage.
3= People with typical biliary pain but no other abnormalities.

Management:

  • Low fat diet
  • Bile acid sequestrants (e.g. cholestyramine) for lower GI symptoms
  • PPI if dyspepsia
  • Nifedipine as smooth ,uscle relaxant.
74
Q

What is the ideal diet for a patient with cirrhosis?

A

Low salt, High calorie/Protein

75
Q

What are the main brush border enzymes?

A

Maltase - cleaves disaccharide maltose to glucose + glucose
Sucrase - cleaves sucrose to fructose and glucose.
Lactase - cleaves disaccharide lactose to glucose + galactose

76
Q

Describe Refeeding syndrome, its features, risk factors, and management.

A

Describes the metabolic abnormalities that occur due to rapid intake of calories typically after a low calorie diet. The Metabolic consequences include hypophosphataemia, hypokalaemia, hypomagnesaemia, abnormal fluid balance.

Features: rhabdomyolysis, respiratory or cardiac failure, hypotension, arrhythmias, seizures, coma, sudden death.

Risk factors:

  • One or more of the following: BMI less than 16, Unintentional weight loss over 15% in 3-6 months, little nutritional intake for over 10 days, hypokalaemia, hypophosphataemia or hypomagnesaemia prior to feeding.
  • two or more of the following: BMI less than 18.5, Unintentional weight loss over 10% in 3-6 months, little nutritional intake for 5 days, history of ETOH abuse, Insulin, chemotherapy, diuretics, antacids.

Management:

  • Monitor PO4, MG, K and replace as appropriate
  • NICE recommend that if a patient hasn’t eaten for over 5 days aim to re-feed at no mora that 50% of requirements for the first 2 days.
77
Q

What is the UKELD score?

A

United Kingdom Model for End-Stage Liver Disease, a medial scoring system used to predict the prognosis of patients with chronic liver disease.

UKELD Score = (5.395 x ln INR) + (1.485 x ln Crea) + (3.13 x ln Bili) - (81.565 x ln Na) + 435

Higher UKELD score equates to high one-year mortality. A UKELD score of 49 indicates a 9% one year risk of mortality and is the minimum score required to be added to the liver transplant waiting list. A UKELD of 60 indicates a 50% one-year survival.

78
Q

Describe MALT Lymphoma, its features, and management

A

A form of lymphoma involving the mucosa-associated lymphoid tissue, frequently of the stomach, but can occur at any muscosal site. It is a cancer originating from B cells in the marginal zone of the MALT.

Features: Weight loss, UGIB, Anaemia

Management:

  • H.pylori eradication first line if +ve (Early stage gastric disease can be cured by this)
  • Radio-chemotherapy. (Rituximab)
79
Q

What is a Dieulafoy Lesion?

A

Large tortuous arteriole most commonly in the stomach wall that erodes and bleeds. It can present in any part of the gastrointestinal tract. Thought to cause less than 5% of all GI bleeds in adults.

80
Q

Describe Gastric Antral Vascular Ectasia (GAVE), and its features

A

An uncommon cause of chronic gastrointestinal bleeding or IDA. The condition is associated with donated small blood vessels in the antrum of the stomach. Also known as watermelon stomach because streaky long red areas that are present in the stomach may represent the markings on watermelon.

Features: Anaemia and blood loss, malaenia, seen on OGD.

Associations: Portal Hypertension, Chronic kidney Disease, Collagen Vascular disease,. Systemic sclerosis

81
Q

Describe Hepatopulmonary syndrome and its features.

A

A syndrome of SOB and Hypoxia caused by vasodilation in the lungs of patients with liver disease, causing over perfusion relative to ventilation and therefore an ventilation-perfusion mismatch. The is an increased A-a gradient.

Features: Platypnoea (More breathless sitting upright) Orthodeoxia (More hypoxia sitting upright)

82
Q

Describe Small Bowel Bacterial Overgrowth syndrome, and its features.

A

A disorder of excessive bacterial growth in the small intestine.

Features: Nausea, Vomiting, diarrhoea, malnutrition, weight loss, malabsorption.

83
Q

What are the indications for a TIPS procedure?

A
  • Uncontrolled Variceal haemorrhage
  • Refractory ascites
  • Hepatic Pleural effusion

-More controversial indications include hepatorenal syndrome, budd-Chiari, bridge to transplantation, veno-occlusive disease

Absolute contraindications:

  • Severe progressive liver failure (child Pugh C)
  • Severe encephalopathy
  • polycystic liver disease
  • severe right heart failure
84
Q

What are some causes of both extrahepatic and intrahepatic duct dilatation?

A

Primary Sclerosing Cholangitis

Cholangiocarcinoma

85
Q

How can LFTs help differentiate between NAFLD and ALD?

A

NAFLD - ALT is greater than AST

ALD - AST is greater than ALT

86
Q

What is tropical sprue?

A

A malabsorption syndrome commonly found in tropical regions, marked with abnormal flattening of villi and inflammation of the lining of the small intestine.

Thought to be due to persistent bacterial, viral, amoebas or parasitic infections. Small intestinal bacteria all overgrowth, folic acid deficiency may also contribute to disorder.

87
Q

Which autoantibodies can help discriminate between Crohn’s and UC?

A

Anti Saccharomyces Cerevisae Antibodies more common in Crohn’s

pANCA more common in Ulcerative colitis

88
Q

Describe Barrett’s Oesopagus and its management

A

Refers to metaplasia of the lower portion of the oesophagus characterised by the replacement of normal stratified epithelium with simple columned epithelium with goblet cells. It has a strong association with oesophageal adenocarcinoma. Thought to be due to chronic acid exposure

Management:

  • 2 yearly surveillance with quadrantic biopsies per 2 cm affected + any visible lesion
  • If biopsy shows low grade dysplasia, first extensive re-biopsy after intensive acid suppression for 8-12 weeks. If still present 6-12mnthly OGD (If regresses after 2 x OGD then back to 2yrly
  • If biopsy shows high grade dysplasia patient need MDT and likely resection or radiofrequency ablation.
89
Q

Describes Gilbert’s syndrome and its features

A

A harmless disorder of bilirubin metabolism. It is the commonest form of inherited non-haemolytic unconjugated hyperbilirubinaemia. Characterised by increasing bilirubin during fasting, physical exertion, and psychological stress, febrile illness and mentstraution.

A diagnosis is made if a patient has had hyperbilirubinaemia either constantly or on at least two occasions over a 6month periods the remainder of liver tests should be normal and haemolysis excluded via blood film, reticulocyte and serum haptoglobin.

90
Q

What is Russell’s Sign?

A

Callous formation over the knuckles on the back of the hand due to repeated self-induced vomiting.

91
Q

Which resource can be used to clarify drug hepatotoxicity?

A

Liver Tox Website